Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Shares Issued (2019 - 2025)

Historic Shares Issued for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to $831.7 million.

  • Avidity Biosciences' Shares Issued rose 15689.17% to $831.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $836.9 million, marking a year-over-year increase of 973.68%. This contributed to the annual value of $762.2 million for FY2024, which is 115879.23% up from last year.
  • Latest data reveals that Avidity Biosciences reported Shares Issued of $831.7 million as of Q3 2025, which was up 15689.17% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Shares Issued registered a high of $831.7 million during Q3 2025, and its lowest value of -$500000.0 during Q4 2024.
  • Its 5-year average for Shares Issued is $153.5 million, with a median of $38.2 million in 2022.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 14168235.29% in 2022, then tumbled by 9918.83% in 2025.
  • Over the past 5 years, Avidity Biosciences' Shares Issued (Quarter) stood at $174.4 million in 2021, then surged by 197.83% to $519.3 million in 2022, then crashed by 92.66% to $38.1 million in 2023, then tumbled by 101.31% to -$500000.0 in 2024, then surged by 166442.0% to $831.7 million in 2025.
  • Its Shares Issued stands at $831.7 million for Q3 2025, versus $3.8 million for Q2 2025 and $1.9 million for Q1 2025.